- Drug Class
- Beta-1 Selective Blocker
- Mechanism of Action (MOA)
- Selective β1 antagonist → ↓ heart rate, ↓ contractility, ↓ AV conduction & myocardial O₂ demand.
- Clinical Notes
- Succinate (ER) is the HF-approved salt; β1-selective.
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
All pharmacology